Novo Design Systems

CAESA = Computer Assisted Estimation of Synthetic Accessibility CSD = Cambridge Structural Database DLD = dynamic ligand design FEP = free energy perturbation MCSS = maximum common substructure PDB = Protein Data Bank. 

In practice these components are sometimes combined so that structures are scored as they are generated and only high scoring part structures are retained. Several of the programs described can also be applied to the generation of structures to fit a pharmacophore hypothesis (when the receptor site is unknown). The main difference here is the way in which the constraints are derived, as described in the following section. 

The simple rules used in the above approaches are derived from statistical analyses of crystallographic databases. This 

The maximum common substructure (MCSS) procedure developed by Miranker and Karplus locates the interaction sites by flooding the active site with many thousands of copies of randomly orientated functional groups (acetate, methanol, methane, methyl ammonium, and water) which are subjected to simultaneous energy minimization and/or molecular dynamics (MD). The local minima are further explored, to account for the flexibility of the receptor, via grid-searching or constrained 

If there is no accurate structural information regarding the receptor, an attempt can be made to create a picture (the pharmacophore) of the receptor binding requirements from an analysis of molecules which are known to bind. There are two major problems inherent in this approach  

---

Furthermore, even if the biological receptor is known and structurally determined, modern techniques such as virtual screening and docking experiments or de novo design systems have to take into account several alternative conformations of the small molecules under investigation to estimate and rank different binding modes and constants with locally optimized electrostatic and steric interactions between the ligand and its receptor [8]. 

In contrast to the use of self-assembly reactions and metal ion coordination preferences to direct the construction of mixed cofactor systems, the use of SPPS or selective chemical ligation allows for the direct covalent attachment of cofactors for the construction of mixed cofactor systems within de novo design. Figure 11 shows the flavocy-tochrome maquette constructed by Dutton and co-workers (149) using a flavin moiety covalently attached to a unique cysteine residue inside a four helix bundle with bis-histidine binding sites for heme... 

Ryadnov MG, Ceyhan B, Niemeyer CM, Woolfson DN. Belt and braces a peptide-based linker system of de novo design. J Am Chem Soc 2003 125 9388-9394. 

A major advancement derived from research into homo- versus heterodimerization specificity includes the use of de novo designed coiled coils for applications that require selective heterodimerization, such as was described by Tripet et al., 67 who developed a unique affinity matrix protein tag system as a rapid and sensitive method to detect, purify, and characterize newly expressed recombinant peptides and proteins from cell extracts. In... 

Therefore, de novo designed two-stranded parallel and antiparallel coiled coils become ideal model systems to study the factors that contribute to our understanding of protein folding and assembly. 

From Table 1 it can be seen that if the size of the i, i+4 lactam is decreased by the incorporation of Asp in place of Glu [DK (i, i+4)], a peptide with only 22% helical structure results under benign conditions and 34% in 50% TFE, compared to 99 and 105%, respectively, for its lactam counterpart, 2EK (i, i+4). Note that it also exhibits less helicity than its linear counterpart, linear 2DK, with values of 27 and 83%, respectively, in the absence and presence of 50% TFE. Clearly, in this de novo designed model system, DK lactams result in peptides with destabilized helices. 

The following new trends in enzymatic synthesis can be delineated the development of new enzymatic reactions enzyme immobilization and stabilization the use of organic solvents and two phase systems site-directed mutagenesis chemical modification of enzymes antibody catalysis catalysis by RNA and DNA de novo design ofbiocatalists employment of recombinant DNA for production of enzymes and use computational and combinatorial methods... 

---